Neural Therapeutics Inc.
Neural Therapeutics Inc.
CSE Index:
Currency:
Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company’s innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.
Neural Therapeutics Inc. (NURL)
SEDAR Information
Company Info
Address
3002-130 Adelaide St. W.
Toronto, ON M5H 3P5
CanadaPhone
647-697-6875Email
info@neuraltherapeutics.comWebsite
http://www.neuraltherapeutics.caListing date
Monday, March 17, 2025Transfer Agent
Odyssey Trust CompanyCapitalization
Issued & Outstanding:
88700524Reserved for Issuance:
31203436Company Officers
Ian Campbell, Chief Executive Officer
Omar Gonzalez, Chief Financial Officer
News Releases
Bulletins
13/03/2025
2025-0315 - New Listing - Neural Therapeutics Inc. (NURL)
le 13 mars/March 2025
The common shares of Neural Therapeutics Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
